-
Product Insights
Neisseria meningitidis Infections - Drugs In Development, 2024
Empower your strategies with our Neisseria meningitidis Infections – Drugs In Development, 2024 report and make more profitable business decisions. Neisseria Meningitidis is a severe bacterial infection of the bloodstream and meninges (a thin lining covering the brain and spinal cord). Symptoms include fever, neck stiffness, joint pain, nausea, confusion and drowsiness. Risk factors include age, smoking, mucosal lesions, overcrowding, climatic conditions such as dry seasons or prolonged drought and dust storms and concomitant respiratory infections. The Neisseria meningitidis Infections drugs...
-
Product Insights
Influenza A Virus, H5N1 Subtype Infections - Drugs In Development, 2024
Empower your strategies with our Influenza A Virus, H5N1 Subtype Infections – Drugs In Development, 2024 report and make more profitable business decisions. H5N1 is a type of influenza virus that causes a highly infectious, severe respiratory disease in birds called avian influenza. This virus can spread to humans. Symptoms include fever and cough, acute respiratory distress, shortness of breath/difficulty breathing, abdominal pain, and diarrhea. Predisposing factors include working with poultry, touching an infected bird, and eating raw or undercooked poultry...
-
Product Insights
Poliomyelitis - Drugs In Development, 2024
Empower your strategies with our Poliomyelitis – Drugs In Development, 2024 report and make more profitable business decisions. Polio is a highly infectious disease caused by a virus. It invades the nervous system and can cause total paralysis in a matter of hours. Symptoms include fever, fatigue, headache, vomiting, stiffness in the neck, and pain in the limbs. Preventive measures such as the use of vaccines are effective for polio. The Poliomyelitis drugs in development market research report provide comprehensive information...
-
Product Insights
Bacterial Vaginosis - Drugs In Development, 2024
Empower your strategies with our Bacterial Vaginosis – Drugs In Development, 2024 report and make more profitable business decisions. Bacterial vaginosis (BV), also known as vaginal bacteriosis, is a type of vaginal inflammation caused by the overgrowth of bacteria present in the vagina. Symptoms include vaginal itching, burning during urination, and watery and thin vaginal discharge. Treatment includes antibiotics. The Bacterial Vaginosis drugs in development market research report provide comprehensive information on the therapeutics under development for Bacterial Vaginosis, complete with...
-
Product Insights
Human Herpesvirus 8 (HHV-8) Infections - Drugs In Development, 2024
Empower your strategies with our Human Herpesvirus 8 (HHV-8) Infections – Drugs In Development, 2024 report and make more profitable business decisions. Human herpesvirus-8 (HHV-8), also known as Kaposi's sarcoma-associated herpesvirus (KSHV), is a gamma herpesvirus that infects various cell types, including endothelial cells, lymphocytes, and dendritic cells. HHV-8 is the etiological agent of Kaposi's sarcoma (KS), a vascular tumor that often affects immunocompromised individuals, such as those with AIDS or organ transplant recipients. HHV-8 is also associated with rare lymphoproliferative...
-
Product Insights
Leishmaniasis (Kala-Azar) - Drugs In Development, 2024
Empower your strategies with our Leishmaniasis (Kala-Azar) – Drugs In Development, 2024 report and make more profitable business decisions. Leishmaniasis is an infection caused by a parasite that is spread to people through the bite of the female phlebotomine sand fly. Symptoms include weight loss, low blood counts, enlargement of the liver and spleen, and fever. Treatment includes anti-parasitic drugs. The Leishmaniasis (Kala-Azar) drugs in development market research report provide comprehensive information on the therapeutics under development for Leishmaniasis (Kala-Azar), complete...
-
Product Insights
Haemophilus influenzae Infections - Drugs In Development, 2024
Empower your strategies with our Haemophilus influenzae Infections – Drugs In Development, 2024 report and make more profitable business decisions. Haemophilus influenzae disease is an infection caused by the bacterium Haemophilus influenzae. Haemophilus influenzae is a bacteria characterized as a small, facultatively anaerobic, pleomorphic, and capnophilic gram-negative coccobacillus of the family Pasteurellaceae. It is a common cause of a variety of invasive and non-invasive bacterial infections. The Haemophilus influenzae Infections drugs in development market research report provide comprehensive information on the...
-
Product Insights
Kaposi Sarcoma - Drugs In Development, 2024
Empower your strategies with our Kaposi Sarcoma – Drugs In Development, 2024 report and make more profitable business decisions. Kaposi's sarcoma is a cancer that causes patches of abnormal tissue to grow under the skin; in the lining of the mouth, nose, and throat; or in other organs. Symptoms include patches that are usually red or purple and are made of cancer cells and blood cells. Lesions that develop in the stomach and intestines can cause abdominal pain and diarrhea. The...
-
Product Insights
Norovirus Infections - Drugs In Development, 2024
Empower your strategies with our Norovirus Infections – Drugs In Development, 2024 report and make more profitable business decisions. Noroviruses are nonenveloped, positive-sense, single-stranded RNA viruses belonging to the Caliciviridae viral family. It is a highly contagious virus causing gastroenteritis, leading to stomach and intestinal inflammation. A common cause of outbreaks of diarrhea and vomiting in schools, cruise ships, hospitals, and community gatherings, it's nicknamed the "winter vomiting bug" due to prevalence in colder months. Symptoms encompass nausea, vomiting, diarrhea, and...
-
Product Insights
Polyomavirus Infections - Drugs In Development, 2024
Empower your strategies with our Polyomavirus Infections – Drugs In Development, 2024 report and make more profitable business decisions. Polyomaviruses, a family of small DNA viruses, pose potential threats to human health. Among them, the BK virus (BKV) and JC virus (JCV) are known to infect humans, with implications for those with weakened immune systems. While these viruses can circulate without symptoms in the general population, immunocompromised individuals face complications. BKV may induce nephropathy or cystitis, particularly in organ transplant recipients....
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.